ID AMPPA_METM7 Reviewed; 505 AA. AC A6VIW6; DT 15-JAN-2008, integrated into UniProtKB/Swiss-Prot. DT 21-AUG-2007, sequence version 1. DT 27-MAR-2024, entry version 91. DE RecName: Full=AMP phosphorylase {ECO:0000255|HAMAP-Rule:MF_02132}; DE Short=AMPpase {ECO:0000255|HAMAP-Rule:MF_02132}; DE EC=2.4.2.57 {ECO:0000255|HAMAP-Rule:MF_02132}; DE AltName: Full=Nucleoside monophosphate phosphorylase {ECO:0000255|HAMAP-Rule:MF_02132}; DE Short=NMP phosphorylase {ECO:0000255|HAMAP-Rule:MF_02132}; GN OrderedLocusNames=MmarC7_1329; OS Methanococcus maripaludis (strain C7 / ATCC BAA-1331). OC Archaea; Euryarchaeota; Methanomada group; Methanococci; Methanococcales; OC Methanococcaceae; Methanococcus. OX NCBI_TaxID=426368; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C7 / ATCC BAA-1331; RG US DOE Joint Genome Institute; RA Copeland A., Lucas S., Lapidus A., Barry K., Glavina del Rio T., Dalin E., RA Tice H., Pitluck S., Clum A., Schmutz J., Larimer F., Land M., Hauser L., RA Kyrpides N., Anderson I., Sieprawska-Lupa M., Whitman W.B., Richardson P.; RT "Complete sequence of Methanococcus maripaludis C7."; RL Submitted (JUN-2007) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Catalyzes the conversion of AMP and phosphate to adenine and CC ribose 1,5-bisphosphate (R15P). Exhibits phosphorylase activity toward CC CMP and UMP in addition to AMP. Functions in an archaeal AMP CC degradation pathway, together with R15P isomerase and RubisCO. CC {ECO:0000255|HAMAP-Rule:MF_02132}. CC -!- CATALYTIC ACTIVITY: CC Reaction=AMP + phosphate = adenine + alpha-D-ribose 1,5-bisphosphate; CC Xref=Rhea:RHEA:36975, ChEBI:CHEBI:16708, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:68688, ChEBI:CHEBI:456215; EC=2.4.2.57; CC Evidence={ECO:0000255|HAMAP-Rule:MF_02132}; CC -!- CATALYTIC ACTIVITY: CC Reaction=CMP + phosphate = alpha-D-ribose 1,5-bisphosphate + cytosine; CC Xref=Rhea:RHEA:36987, ChEBI:CHEBI:16040, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:60377, ChEBI:CHEBI:68688; EC=2.4.2.57; CC Evidence={ECO:0000255|HAMAP-Rule:MF_02132}; CC -!- CATALYTIC ACTIVITY: CC Reaction=phosphate + UMP = alpha-D-ribose 1,5-bisphosphate + uracil; CC Xref=Rhea:RHEA:36991, ChEBI:CHEBI:17568, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:57865, ChEBI:CHEBI:68688; EC=2.4.2.57; CC Evidence={ECO:0000255|HAMAP-Rule:MF_02132}; CC -!- SIMILARITY: Belongs to the thymidine/pyrimidine-nucleoside CC phosphorylase family. Type 2 subfamily. {ECO:0000255|HAMAP- CC Rule:MF_02132}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; CP000745; ABR66392.1; -; Genomic_DNA. DR AlphaFoldDB; A6VIW6; -. DR SMR; A6VIW6; -. DR STRING; 426368.MmarC7_1329; -. DR KEGG; mmz:MmarC7_1329; -. DR eggNOG; arCOG02013; Archaea. DR HOGENOM; CLU_025040_6_0_2; -. DR OrthoDB; 9827at2157; -. DR GO; GO:0004645; F:1,4-alpha-oligoglucan phosphorylase activity; IEA:InterPro. DR GO; GO:0016208; F:AMP binding; IEA:UniProtKB-UniRule. DR GO; GO:0016763; F:pentosyltransferase activity; IEA:UniProtKB-UniRule. DR GO; GO:0006196; P:AMP catabolic process; IEA:UniProtKB-UniRule. DR GO; GO:0046125; P:pyrimidine deoxyribonucleoside metabolic process; IEA:InterPro. DR GO; GO:0006206; P:pyrimidine nucleobase metabolic process; IEA:InterPro. DR Gene3D; 1.20.970.50; -; 1. DR Gene3D; 2.40.40.20; -; 1. DR Gene3D; 3.40.1030.10; Nucleoside phosphorylase/phosphoribosyltransferase catalytic domain; 1. DR Gene3D; 3.90.1170.30; Pyrimidine nucleoside phosphorylase-like, C-terminal domain; 1. DR HAMAP; MF_02132; AMP_phosphorylase; 1. DR InterPro; IPR017713; AMP_phosphorylase. DR InterPro; IPR000312; Glycosyl_Trfase_fam3. DR InterPro; IPR017459; Glycosyl_Trfase_fam3_N_dom. DR InterPro; IPR036320; Glycosyl_Trfase_fam3_N_dom_sf. DR InterPro; IPR035902; Nuc_phospho_transferase. DR InterPro; IPR036566; PYNP-like_C_sf. DR InterPro; IPR013102; PYNP_C. DR InterPro; IPR017872; Pyrmidine_PPase_CS. DR InterPro; IPR013466; Thymidine/AMP_Pase. DR InterPro; IPR000053; Thymidine/pyrmidine_PPase. DR NCBIfam; TIGR03327; AMP_phos; 1. DR NCBIfam; TIGR02645; ARCH_P_rylase; 1. DR PANTHER; PTHR10515; THYMIDINE PHOSPHORYLASE; 1. DR PANTHER; PTHR10515:SF0; THYMIDINE PHOSPHORYLASE; 1. DR Pfam; PF02885; Glycos_trans_3N; 1. DR Pfam; PF00591; Glycos_transf_3; 1. DR Pfam; PF07831; PYNP_C; 1. DR PIRSF; PIRSF000478; TP_PyNP; 1. DR SMART; SM00941; PYNP_C; 1. DR SUPFAM; SSF52418; Nucleoside phosphorylase/phosphoribosyltransferase catalytic domain; 1. DR SUPFAM; SSF47648; Nucleoside phosphorylase/phosphoribosyltransferase N-terminal domain; 1. DR SUPFAM; SSF54680; Pyrimidine nucleoside phosphorylase C-terminal domain; 1. DR PROSITE; PS00647; THYMID_PHOSPHORYLASE; 1. PE 3: Inferred from homology; KW Glycosyltransferase; Transferase. FT CHAIN 1..505 FT /note="AMP phosphorylase" FT /id="PRO_0000314724" FT ACT_SITE 258 FT /note="Proton donor" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02132" FT BINDING 170 FT /ligand="AMP" FT /ligand_id="ChEBI:CHEBI:456215" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02132" FT BINDING 196..201 FT /ligand="AMP" FT /ligand_id="ChEBI:CHEBI:456215" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02132" FT BINDING 205 FT /ligand="AMP" FT /ligand_id="ChEBI:CHEBI:456215" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02132" FT BINDING 266 FT /ligand="AMP" FT /ligand_id="ChEBI:CHEBI:456215" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02132" FT BINDING 290 FT /ligand="AMP" FT /ligand_id="ChEBI:CHEBI:456215" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02132" SQ SEQUENCE 505 AA; 54585 MW; 6820393DF490FF6F CRC64; MLFLNAKFID LDLGESAVIV NEEDLKGTSY YPQDRVLIES HAGSVIGNIY STKTMVQKGE VGMLVSELSE ISISEGEEVK LRHAEKPESI PFIKKKMDGQ VLNPHEIRTI IDEIVSKKLS NIELSAFVSS TYINGMNMDE ISEMTKRIAE TGDMISWEKS LVVDIHSIGG VPGNKYALLS IPILAAAGIT VPKTSSRAIT SPAGTADVME VLTNVELKEE EIKRIVKTTN GCLAWGGGVN LAPADDIIIN VERPVSIDPQ PQLLASVMAK KIATGIKYTV IDIPVGKGVK IKNEAEGAKL ARKFIELGEM LNIKVECVLT YGGQPLGRAI GPALEAKEAI ESLQDPKNAP KSLIEKSLSL AGILLELGGA AQIGEGQNLA WEILESGKAL EKFNQIIVEQ GGTPKKPEEI ELGEYVEEIL APIDGYITDI SNTAITNVVK EAGAPRDKKA GILLNSKIGN KVTQGDVLYT IYSGSEERLI SAVNLARRVY PVKVEGMLIE RISKF //